Thomas A. Satterfield, Jr. 13D and 13G filings for Edesa Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-18 4:15 pm Sale | 2025-02-13 | 13G | Edesa Biotech, Inc. EDSA | Thomas A. Satterfield, Jr. | 0 0.000% | -232,161 (Position Closed) | Filing |
| 2025-02-12 08:00 am Purchase | 2024-12-31 | 13G | Edesa Biotech, Inc. EDSA | Thomas A. Satterfield, Jr. | 232,161 6.700% | 56,117 (+31.88%) | Filing |
| 2024-06-03 4:10 pm Purchase | 2024-05-30 | 13G | Edesa Biotech, Inc. EDSA | Thomas A. Satterfield, Jr. | 176,044 5.470% | 176,044 (New Position) | Filing |